Gossamer Bio, Inc. Quarterly Interest Expense in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Gossamer Bio, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2019 to Q1 2024.
  • Gossamer Bio, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.13M, a 10.6% decline year-over-year.
  • Gossamer Bio, Inc. Interest Expense for the twelve months ending March 31, 2024 was $13.1M, a 5.56% decline year-over-year.
  • Gossamer Bio, Inc. annual Interest Expense for 2023 was $13.5M, a 2.66% decline from 2022.
  • Gossamer Bio, Inc. annual Interest Expense for 2022 was $13.9M, a 28.6% decline from 2021.
  • Gossamer Bio, Inc. annual Interest Expense for 2021 was $19.4M, a 53.5% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.1M $3.13M -$371K -10.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.5M $3.24M -$218K -6.31% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $13.7M $3.34M -$132K -3.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $13.9M $3.43M -$52K -1.49% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $13.9M $3.5M +$33K +0.95% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $13.9M $3.46M -$1.48M -30% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $15.4M $3.48M -$1.41M -28.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $16.8M $3.48M -$1.35M -28% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $18.1M $3.47M -$1.31M -27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $19.4M $4.94M +$184K +3.87% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 $19.3M $4.89M +$174K +3.69% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $19.1M $4.83M +$2.34M +94.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $16.7M $4.78M +$4.07M +576% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $12.7M $4.75M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 $4.72M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $2.49M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $707K +$688K +3621% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $19K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.